Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment
2022 · Journal of Nanobiotechnology · 222 citations
https://doi.org/10.1186/s12951-022-01746-6
S
Shengli Wan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
523
Citations
10
h-index
12
i10-index
Shengli Wan is an academic researcher from Southwest Medical University. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Nanoplatforms for cancer theranostics & Extracellular vesicles in disease. The author has an h-index of 10, co-authored 18 publications.
Papers by this author
worksTargeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 13 citations
https://doi.org/10.1016/j.bbcan.2025.189259
Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment
2024 · Pharmacological Research · 6 citations
https://doi.org/10.1016/j.phrs.2024.107068
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat